Health & Personal Care
HIGH
FDA DRUG
Invagen Pharmaceuticals Recalls Lanthanum Carbonate Tablets for Safety Risk
Failed stability specifications: Out of specification for hardness test
LANTHANUM CARBONATE
Failed stability
Brand hub
Failed stability specifications: Out of specification for hardness test
Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.